Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

( sup 3 H)cytisine binding to nicotinic cholinergic receptors in brain

Journal Article · · Molecular Pharmacology; (USA)
OSTI ID:5988845
; ;  [1]
  1. Georgetown Univ. School of Medicine, Washington, DC (USA)
Cytisine, a ganglionic agonist, competes with high affinity for brain nicotinic cholinergic receptors labeled by any of several nicotinic {sup 3}H-agonist ligands. Here we have examined the binding of ({sup 3}H)cytisine in rat brain homogenates. ({sup 3}H)Cytisine binds with high affinity (Kd less than 1 nM), and specific binding represented 60-90% of total binding at all concentrations examined up to 15 nM. The nicotinic cholinergic agonists nicotine, acetylcholine, and carbachol compete with high affinity for ({sup 3}H)cytisine binding sites, whereas among nicotinic receptor antagonists only dihydro-beta-erythroidine competes with high affinity (in the nanomolar range). Comparison of binding in several brain regions showed that ({sup 3}H)cytisine binding is higher in the thalamus, striatum, and cortex than in the hippocampus, cerebellum, or hypothalamus. The pharmacology and brain regional distribution of ({sup 3}H)cytisine binding sites are those predicted for neuronal nicotinic receptor agonist recognition sites. The high affinity and low nonspecific binding of ({sup 3}H)cytisine should make it a very useful ligand for studying neuronal nicotinic receptors.
OSTI ID:
5988845
Journal Information:
Molecular Pharmacology; (USA), Journal Name: Molecular Pharmacology; (USA) Vol. 39:1; ISSN MOPMA; ISSN 0026-895X
Country of Publication:
United States
Language:
English